Snellen vs. LogMAR: Why a 164-Year-Old Eye Chart Is No Longer Enough

October 9, 2026
Snellen vs. LogMAR: Why a 164-Year-Old Eye Chart Is No Longer Enough
Published on  Updated on  

The Snellen eye chart has been a fixture of clinical eye care since 1862. More than 160 years later, its familiar rows of progressively smaller letters still influence decisions about visual performance, referrals, treatment monitoring and disability eligibility. Yet the requirements placed on visual acuity measurements have changed considerably since Hermann Snellen developed his chart.

Modern ophthalmology increasingly depends on detecting relatively small changes in visual function, comparing results across clinical studies and maintaining consistent records over time. Conventional Snellen charts were not constructed around the same standardized principles as contemporary logMAR charts, and that distinction has measurable consequences.

The question is no longer simply whether Snellen testing works. It is whether a test designed in the nineteenth century offers the consistency, precision and reproducibility expected of modern clinical measurement.

Snellen vs. LogMAR: The Difference Is Built Into the Chart

The limitations of conventional Snellen charts begin with their construction. Although the letters become progressively smaller, the number of optotypes per line and the spacing between them are not consistently controlled across traditional chart designs. Scoring commonly depends on the smallest line a patient can read, making partial-line performance more difficult to express consistently.

LogMAR charts address these structural problems through a logarithmic progression of optotype sizes and standardized spacing. The widely used ETDRS design contains five letters on each line, with a consistent 0.1 logMAR change between successive lines.

Each correctly identified letter represents 0.02 logMAR when scored individually. This creates a structured measurement scale that supports more detailed comparisons between examinations.

For context, 20/20 Snellen acuity corresponds to 0.0 logMAR, 20/40 to approximately 0.3 logMAR, and 20/200 to 1.0 logMAR.

The distinction is not simply how the results are written. LogMAR describes the acuity scale, while ETDRS is a standardized chart design and testing approach. Using both together can reduce sources of measurement variation that remain less controlled in conventional Snellen testing.

The Clinical Evidence: A Difference of 6.5 Letters

One of the clearest demonstrations of the difference comes from a prospective clinical comparison published in Transactions of the American Ophthalmological Society. Researchers assessed best-corrected visual acuity in 163 eyes using projected Snellen charts and back-illuminated ETDRS charts under standardized conditions. The resulting measurements were not interchangeable.

The mean Snellen result was 20/94 (0.67 logMAR), while the mean ETDRS result at four meters was approximately 20/69 (0.54 logMAR). The ETDRS score was on average 6.5 letters better (P = 0.000000001).

The difference was most pronounced among participants with poorer vision. For patients whose acuity was worse than 20/200, the discrepancy between chart results reached 0.2 logMAR, equivalent to two standard logMAR lines or ten ETDRS letters.

That is a substantial difference when an eye care professional is assessing changes in visual function. It also illustrates the danger of comparing measurements from different chart systems as though they were obtained using the same method.

Importantly, the study did not establish that ETDRS will always produce better results by 6.5 letters. It demonstrated that chart selection can systematically influence recorded acuity and that the discrepancy may become greater as visual acuity deteriorates.

For low-vision patients and people undergoing repeated clinical assessment, that distinction deserves attention.

Repeatability: Where LogMAR Scoring Has a Measurable Advantage

A chart used to monitor disease progression must do more than produce a plausible acuity value. It must also deliver reasonably consistent results when the same patient is tested again under comparable conditions.

Traditional line-based scoring can introduce additional variation because patients rarely perform perfectly at their visual threshold. One examination may end when a patient completes a particular line, while another may include several additional letters from the next line.

Standardized letter-by-letter scoring records those differences directly. In a study published in Eye, researchers compared scoring approaches using ETDRS charts in 32 patients with macular disease and 38 age-matched participants with normal vision.

The investigators found that traditional line-assignment scoring produced greater test-retest variability than either ETDRS letter-by-letter scoring or probit scoring. The within-test standard deviation for the latter approaches was approximately 0.04 logMAR, equivalent to two ETDRS letters.

This finding is especially important because the study used the same underlying ETDRS charts to evaluate scoring methods. It demonstrates that precision depends not only on chart design but also on how patient responses are recorded.

A conventional Snellen result may be sufficient for identifying broad acuity differences. However, when clinicians need to distinguish relatively small changes across examinations, standardized charts combined with letter-by-letter scoring offer a more defensible measurement approach.

The Conversion Problem: A LogMAR Number Is Not Necessarily a LogMAR Measurement

A particularly important distinction appears in research and retrospective clinical data. Converting a Snellen fraction to logMAR is mathematically straightforward. A recorded acuity of 20/40 can be expressed as approximately 0.3 logMAR.

But this does not mean the original test was performed with a standardized logMAR chart. The conversion changes the numerical representation, not the conditions under which the patient was tested. It cannot reconstruct missing letters, correct nonstandard spacing or establish how partial lines were scored.

This problem is more than theoretical. A 2023 review in the Journal of Clinical Medicine examined 295 keratoconus research articles published between 2017 and 2022.

The review found that 150 articles did not identify the chart used to measure visual acuity, while 68 explicitly reported converting Snellen results to logMAR. The review also identified articles reporting logMAR values without clearly specifying the original testing method, leaving uncertainty about how the measurements had been obtained.

For research comparing treatment outcomes, these omissions matter. A numerical value alone does not demonstrate that participants were assessed using equivalent measurement procedures.

Post-hoc conversion is sometimes necessary when analyzing historical records. The problem arises when converted Snellen data are treated as equivalent to prospectively collected ETDRS measurements without acknowledging differences in chart construction, scoring and test conditions.

As clinical research increasingly relies on routinely collected health records, clearly documenting the original testing methodology becomes even more important.

Why the Difference Matters for Clinical Trials and Treatment Monitoring

Standardized ETDRS testing has become particularly important in ophthalmic research because clinical trials require reproducible outcome measurements. Visual acuity is frequently used to evaluate interventions affecting retinal function, macular disease and other vision-related conditions.

When changes in performance are central to determining treatment outcomes, inconsistencies introduced by chart design or scoring can complicate interpretation. The familiar threshold of 15 ETDRS letters illustrates why the measurement system matters.

On a standard ETDRS chart, this represents three lines, or 0.3 logMAR. Clinical studies frequently use letter-based changes in their endpoint definitions, although the significance of a particular change depends on the disease, intervention and protocol.

Conventional Snellen charts are less well suited to this level of standardized letter-based analysis, particularly when the chart itself contains inconsistent numbers of letters or uses line-based scoring. This is why ETDRS methods are so prominent in ophthalmic research.

They provide a structured approach to visual acuity measurement that investigators can reproduce across study visits and participating centers. The distinction should not be confused with a claim that every clinical trial follows one mandatory FDA testing protocol.

Individual studies operate under their specific regulatory and methodological requirements. The broader point remains: research-quality visual acuity data require a defined and consistently applied measurement system.

Documentation: Two Results Can Look Equivalent Without Being Comparable

Visual acuity records can create a false sense of precision when they contain a numerical value but little information about how that value was obtained. Consider two records showing 0.3 logMAR.

One may have originated from a standardized ETDRS examination using letter-by-letter scoring. The other may represent a converted 20/40 result from a conventional Snellen chart. Although the reported numerical values are identical, the underlying measurements are not necessarily equivalent.

For clinicians reviewing longitudinal records, the difference becomes important when a patient changes practices, chart systems or examination protocols. Without knowing how acuity was measured, a recorded improvement or deterioration may partly reflect differences in testing.

Documentation is also relevant to disability assessment. In the United States, Social Security disability criteria include central visual acuity thresholds based on best-corrected vision in the better eye, with specific rules for acceptable testing and interpretation.

LogMAR and Snellen-equivalent values can both contribute to communicating visual acuity, but recording the chart type, correction status and relevant examination details provides better context than a converted number alone. The aim should be to preserve the original measurement and make its interpretation clear, rather than assuming that conversion resolves methodological differences.

Pediatric and Low-Vision Testing: Standardization Becomes Even More Important

The limitations of conventional letter-based Snellen charts are especially apparent when patients cannot reliably recognize letters or complete the standard examination. Young children may require symbol-based tests, while patients with low vision may need charts covering a wider range of acuity levels or modified testing distances.

Logarithmic chart design is not restricted to adult letter charts. LEA SYMBOLS® and other age-appropriate optotype systems are available in standardized formats that support structured visual acuity assessment.

These alternatives are particularly valuable because choosing appropriate optotypes can reduce the influence of language and letter-recognition ability on the examination. However, chart format and patient suitability must be considered together.

A logMAR layout does not automatically make different optotype systems interchangeable, and pediatric screening protocols may require specific chart designs and referral criteria. In patients with reduced vision, the prospective Snellen-versus-ETDRS comparison provides another reason for careful chart selection.

The largest observed discrepancies occurred in the poorest-acuity subgroup, precisely where measuring and documenting residual visual function can be clinically important.

For clinicians considering standardized chart options, the following two Good-Lite products illustrate adult Sloan-letter and symbol-based ETDRS formats used with compatible illuminated cabinets.

Moving Beyond Snellen: What Should Practices Prioritize?

Adopting more standardized visual acuity assessment does not necessarily mean removing every Snellen chart from a practice. It means recognizing situations where a conventional chart provides insufficient measurement detail.

For routine examinations, Snellen notation remains familiar and useful. For clinical trials, repeated disease monitoring, detailed acuity comparisons and other precision-sensitive applications, standardized logMAR/ETDRS methods offer important advantages.

Practices considering a transition should evaluate chart design, testing distance, illumination, optotype selection and examiner training as one connected measurement process. Replacing the chart without standardizing its use will not deliver the full benefit.

Letter-by-letter scoring should also be understood by clinical staff, particularly when small differences in recorded acuity may influence follow-up assessments. Good-Lite provides a range of ETDRS, logMAR and pediatric visual acuity charts for different clinical settings.

Choosing a suitable chart system can help clinicians apply more consistent assessment methods while accommodating the needs of different patient populations.

The Case for LogMAR Is About Better Evidence

More than 160 years after its introduction, Snellen remains recognizable throughout eye care. Familiarity, however, should not be mistaken for measurement equivalence.

The comparative evidence demonstrates that Snellen and ETDRS charts can produce significantly different visual acuity results. Research on scoring methods shows that standardized letter-by-letter scoring reduces test-retest variability compared with traditional line assignment, while published reviews reveal persistent weaknesses in how visual acuity methods are documented.

These findings make a compelling case for more consistent adoption of standardized logMAR-based testing wherever precision and reproducibility matter. The central issue is not whether Snellen testing should disappear.

It is whether clinicians and researchers should continue treating results from different chart systems as interchangeable when published evidence shows they are not. For modern clinical documentation and research, the method behind the number matters as much as the number itself.

Sources

  1. Prospective Evaluation of Visual Acuity Assessment: A Comparison of Snellen Versus ETDRS Charts in Clinical Practice. Transactions of the American Ophthalmological Society, 2009.
  2. Visual acuity scored by the letter-by-letter or probit methods has lower retest variability than the line assignment method. Eye, 1997.
  3. Visual Acuity Examination Methodology in Keratoconus. Journal of Clinical Medicine, 2023.
  4. Social Security Administration disability evaluation: Special Senses and Speech.
Published on  Updated on  

Frequently Asked Questions

Get quick answers to common questions related to this article.

ETDRS charts use a structured logMAR design with standardized optotype sizing and spacing. This makes them well suited to studies where visual acuity measurements need to be collected consistently and compared over time.

Conventional Snellen charts typically vary in letters per line and spacing, while standardized logMAR charts use a consistent logarithmic size progression. ETDRS-style charts also support letter-by-letter scoring, making visual acuity changes easier to quantify across examinations.

Yes. Snellen results can be mathematically converted to logMAR values, but this does not make them equivalent to measurements collected directly with standardized logMAR charts. The original testing method and scoring approach remain important.

A standard ETDRS chart has five letters per line, with each letter contributing 0.02 logMAR. Five letters therefore represent 0.1 logMAR, and 15 letters represent three chart lines.